# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-20-154927
Filing Date
2020-05-29
Accepted
2020-05-29 07:06:02
Documents
34
Period of Report
2020-05-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d845849d8k.htm | 8-K | 30397
2 | EX-99.1 | d845849dex991.htm | EX-99.1 | 20409
3 | EX-99.2 | d845849dex992.htm | EX-99.2 | 30529
4 | GRAPHIC | g845849ex99_2s10g1.jpg | GRAPHIC | 156496
5 | GRAPHIC | g845849ex99_2s11g1.jpg | GRAPHIC | 159848
6 | GRAPHIC | g845849ex99_2s12g1.jpg | GRAPHIC | 254296
7 | GRAPHIC | g845849ex99_2s13g1.jpg | GRAPHIC | 168268
8 | GRAPHIC | g845849ex99_2s14g1.jpg | GRAPHIC | 226961
9 | GRAPHIC | g845849ex99_2s15g1.jpg | GRAPHIC | 221896
10 | GRAPHIC | g845849ex99_2s16g1.jpg | GRAPHIC | 256605
11 | GRAPHIC | g845849ex99_2s17g1.jpg | GRAPHIC | 335939
12 | GRAPHIC | g845849ex99_2s18g1.jpg | GRAPHIC | 161911
13 | GRAPHIC | g845849ex99_2s19g1.jpg | GRAPHIC | 196142
14 | GRAPHIC | g845849ex99_2s1g1.jpg | GRAPHIC | 234241
15 | GRAPHIC | g845849ex99_2s20g1.jpg | GRAPHIC | 166614
16 | GRAPHIC | g845849ex99_2s21g1.jpg | GRAPHIC | 215303
17 | GRAPHIC | g845849ex99_2s22g1.jpg | GRAPHIC | 258510
18 | GRAPHIC | g845849ex99_2s23g1.jpg | GRAPHIC | 176983
19 | GRAPHIC | g845849ex99_2s24g1.jpg | GRAPHIC | 197777
20 | GRAPHIC | g845849ex99_2s25g1.jpg | GRAPHIC | 210409
21 | GRAPHIC | g845849ex99_2s26g1.jpg | GRAPHIC | 188925
22 | GRAPHIC | g845849ex99_2s27g1.jpg | GRAPHIC | 95989
23 | GRAPHIC | g845849ex99_2s28g1.jpg | GRAPHIC | 186541
24 | GRAPHIC | g845849ex99_2s29g1.jpg | GRAPHIC | 293758
25 | GRAPHIC | g845849ex99_2s2g1.jpg | GRAPHIC | 345714
26 | GRAPHIC | g845849ex99_2s30g1.jpg | GRAPHIC | 199265
27 | GRAPHIC | g845849ex99_2s3g1.jpg | GRAPHIC | 236875
28 | GRAPHIC | g845849ex99_2s4g1.jpg | GRAPHIC | 154087
29 | GRAPHIC | g845849ex99_2s5g1.jpg | GRAPHIC | 172821
30 | GRAPHIC | g845849ex99_2s6g1.jpg | GRAPHIC | 193836
31 | GRAPHIC | g845849ex99_2s7g1.jpg | GRAPHIC | 195470
32 | GRAPHIC | g845849ex99_2s8g1.jpg | GRAPHIC | 230420
33 | GRAPHIC | g845849ex99_2s9g1.jpg | GRAPHIC | 223537
34 | GRAPHIC | g845849g0529032831211.jpg | GRAPHIC | 2277
| Complete submission text file | 0001193125-20-154927.txt |  | 8788245

Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 20924022
SIC: 2834 Pharmaceutical Preparations